TARA CASSEL: Open Payments
NPI 1871943506 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 119 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $642 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $269 |
| E.R. Squibb & Sons, L.L.C. | 14 | $248 |
| Lundbeck LLC | 14 | $201 |
| Alkermes, Inc. | 12 | $199 |
| Janssen Pharmaceuticals, Inc | 10 | $167 |
| Vanda Pharmaceuticals Inc. | 11 | $162 |
| Otsuka America Pharmaceutical, Inc. | 15 | $159 |
| Neurocrine BioSciences, Inc. | 10 | $153 |
| Supernus Pharmaceuticals, Inc. | 9 | $135 |
| Axsome Therapeutics, Inc. | 4 | $79 |
Products named: CAPLYTA, COBENFY, ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA, INGREZZA, Qelbree, HETLIOZ.
Industry payments across TN — which companies pay providers there.
